Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as an urgent patient-safety and governance event, not as an earnings-management problem. A suspected fatal or life-threatening adverse effect affecting potentially hundreds of patients is sufficient to trigger immediate escalation, investigation, and regulator contact.Read the full answer
You are facing a test that will define you, the company, and potentially your freedom. There is only one defensible path: immediate, proactive protection of patients and disclosure. Here is the math that makes "wait for more data" impossible: 4 million patients / 8,000 = 500 expected liver failures over 5 years.Read the full answer